Cargando…
Rho-GEF Trio regulates osteosarcoma progression and osteogenic differentiation through Rac1 and RhoA
Osteosarcoma (OS) is the most common primary bone tumor. Its high mortality rate and metastasis rate seriously threaten human health. Currently, the treatment has reached a plateau, hence we urgently need to explore new therapeutic directions. In this paper, we found that Trio was highly expressed i...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664940/ https://www.ncbi.nlm.nih.gov/pubmed/34893584 http://dx.doi.org/10.1038/s41419-021-04448-3 |
_version_ | 1784613946043400192 |
---|---|
author | Wang, Junyi Yuan, Lichan Xu, Xiaohong Zhang, Zhongyin Ma, Yuhuan Hong, Leilei Ma, Junqing |
author_facet | Wang, Junyi Yuan, Lichan Xu, Xiaohong Zhang, Zhongyin Ma, Yuhuan Hong, Leilei Ma, Junqing |
author_sort | Wang, Junyi |
collection | PubMed |
description | Osteosarcoma (OS) is the most common primary bone tumor. Its high mortality rate and metastasis rate seriously threaten human health. Currently, the treatment has reached a plateau, hence we urgently need to explore new therapeutic directions. In this paper, we found that Trio was highly expressed in osteosarcoma than normal tissues and promoted the proliferation, migration, and invasion of osteosarcoma cells. Furthermore, Trio inhibited osteosarcoma cells’ osteogenic differentiation in vitro and accelerated the growth of osteosarcoma in vivo. Given Trio contains two GEF domains, which have been reported as the regulators of RhoGTPases, we further discovered that Trio could regulate osteosarcoma progression and osteogenic differentiation through activating RhoGTPases. In summary, all our preliminary results showed that Trio could be a potential target and prognostic marker of osteosarcoma. |
format | Online Article Text |
id | pubmed-8664940 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-86649402021-12-27 Rho-GEF Trio regulates osteosarcoma progression and osteogenic differentiation through Rac1 and RhoA Wang, Junyi Yuan, Lichan Xu, Xiaohong Zhang, Zhongyin Ma, Yuhuan Hong, Leilei Ma, Junqing Cell Death Dis Article Osteosarcoma (OS) is the most common primary bone tumor. Its high mortality rate and metastasis rate seriously threaten human health. Currently, the treatment has reached a plateau, hence we urgently need to explore new therapeutic directions. In this paper, we found that Trio was highly expressed in osteosarcoma than normal tissues and promoted the proliferation, migration, and invasion of osteosarcoma cells. Furthermore, Trio inhibited osteosarcoma cells’ osteogenic differentiation in vitro and accelerated the growth of osteosarcoma in vivo. Given Trio contains two GEF domains, which have been reported as the regulators of RhoGTPases, we further discovered that Trio could regulate osteosarcoma progression and osteogenic differentiation through activating RhoGTPases. In summary, all our preliminary results showed that Trio could be a potential target and prognostic marker of osteosarcoma. Nature Publishing Group UK 2021-12-11 /pmc/articles/PMC8664940/ /pubmed/34893584 http://dx.doi.org/10.1038/s41419-021-04448-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Wang, Junyi Yuan, Lichan Xu, Xiaohong Zhang, Zhongyin Ma, Yuhuan Hong, Leilei Ma, Junqing Rho-GEF Trio regulates osteosarcoma progression and osteogenic differentiation through Rac1 and RhoA |
title | Rho-GEF Trio regulates osteosarcoma progression and osteogenic differentiation through Rac1 and RhoA |
title_full | Rho-GEF Trio regulates osteosarcoma progression and osteogenic differentiation through Rac1 and RhoA |
title_fullStr | Rho-GEF Trio regulates osteosarcoma progression and osteogenic differentiation through Rac1 and RhoA |
title_full_unstemmed | Rho-GEF Trio regulates osteosarcoma progression and osteogenic differentiation through Rac1 and RhoA |
title_short | Rho-GEF Trio regulates osteosarcoma progression and osteogenic differentiation through Rac1 and RhoA |
title_sort | rho-gef trio regulates osteosarcoma progression and osteogenic differentiation through rac1 and rhoa |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664940/ https://www.ncbi.nlm.nih.gov/pubmed/34893584 http://dx.doi.org/10.1038/s41419-021-04448-3 |
work_keys_str_mv | AT wangjunyi rhogeftrioregulatesosteosarcomaprogressionandosteogenicdifferentiationthroughrac1andrhoa AT yuanlichan rhogeftrioregulatesosteosarcomaprogressionandosteogenicdifferentiationthroughrac1andrhoa AT xuxiaohong rhogeftrioregulatesosteosarcomaprogressionandosteogenicdifferentiationthroughrac1andrhoa AT zhangzhongyin rhogeftrioregulatesosteosarcomaprogressionandosteogenicdifferentiationthroughrac1andrhoa AT mayuhuan rhogeftrioregulatesosteosarcomaprogressionandosteogenicdifferentiationthroughrac1andrhoa AT hongleilei rhogeftrioregulatesosteosarcomaprogressionandosteogenicdifferentiationthroughrac1andrhoa AT majunqing rhogeftrioregulatesosteosarcomaprogressionandosteogenicdifferentiationthroughrac1andrhoa |